Future studies of the KIRs-HLA class I pattern in patients with non-melanoma skin cancer as well as γδ T cells, which have extent distribution in skin[40] and functional studies of NK cells possessing KIR3DL1 in BCC patients, would be a valuable strategy to find out the effect of its presence on the NK cell meddling in cancer immunity. The gene discussed is KIR3DL1; the disease is non-melanoma skin carcinoma.